Acrobiosystems Co Ltd Class A 301080

Morningstar Rating
CN¥74.21 −0.23 (0.31%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

301080 is trading at a LOCK|GKFj@& premium.
Price
CN¥74.44
Fair Value
LOCK|.!<>>h<
Uncertainty
LOCK|>K DBgZ
1-Star Price
LOCK|.#P&?&GW
5-Star Price
LOCK|.>#gLkGR
Economic Moat
LOCK|z^@
Capital Allocation
—

Trading Information

Previous Close Price
CN¥74.44
Day Range
CN¥72.00–75.98
52-Week Range
CN¥35.87–141.99
Bid/Ask
CN¥74.20 / CN¥74.21
Shares Outstanding
167.68M
Market Cap
CN¥12.44B
Volume/Avg
9M / 16M

Key Statistics

Price/Earnings (Normalized)
59.91
Price/Sales
12.15
Dividend Yield (Trailing)
0.81%
Dividend Yield (Forward)
0.81%
Dividend Payment Schedule
Jun
Total Yield
0.81%

Company Profile

Acrobiosystems Co Ltd is a global brand focusing on protein technology, products and services in the development of biological drugs. It is committed to providing target antigens and other key reagents and related services required in the development of targeted therapeutic drugs.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Mid Growth
Total Number of Employees
926

Valuation

Metric
301080
Price/Earnings (Normalized)
59.91
Price/Book Value
4.55
Price/Sales
12.15
Price/Cash Flow
37.00
Price/Earnings
301080

Financial Strength

Metric
301080
Quick Ratio
7.26
Current Ratio
8.96
Interest Coverage
733.29
Quick Ratio
301080

Profitability

Metric
301080
Return on Assets (Normalized)
5.77%
Return on Equity (Normalized)
6.49%
Return on Invested Capital (Normalized)
5.07%
Return on Assets
301080

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Vertex Pharmaceuticals Inc
VRTX
LOCK|H^^zDk^LOCK|D<f#$135B
Regeneron Pharmaceuticals Inc
REGN
LOCK|Q<>m>@%LOCK|MB#@Q$99B
Moderna Inc
MRNA
LOCK|b!B&s?LOCK|p<$84B
argenx SE ADR
ARGX
LOCK|GBGjGxLOCK|VS$59B
BeOne Medicines Ltd ADR
ONC
LOCK|RTN$VYLOCK|&<X$48B
Royalty Pharma PLC Class A
RPRX
LOCK|zSFQxszLOCK|hc&t$31B
Incyte Corp
INCY
LOCK|J%rwdWwLOCK|sJ$24B
BioNTech SE ADR
BNTX
LOCK|T??Vf<LOCK|$j$21B
Alnylam Pharmaceuticals Inc
ALNY
LOCK|VFkM?%LOCK|XKbR!$21B
Jazz Pharmaceuticals PLC
JAZZ
LOCK|gK^!mJmLOCK|v?$15B

Sponsor Center